Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 29114 | 192 | 37.5 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
| 124 | 3 | PARKINSONS DISEASE//MOVEMENT DISORDERS//DEEP BRAIN STIMULATION | 67777 |
| 332 | 2 | PARKINSONS DISEASE//ALPHA SYNUCLEIN//PARKIN | 18089 |
| 29114 | 1 | PRAMIPEXOLE//PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE//TALIPEXOLE | 192 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | PRAMIPEXOLE | authKW | 1063304 | 27% | 13% | 51 |
| 2 | PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE | authKW | 318078 | 1% | 100% | 2 |
| 3 | TALIPEXOLE | authKW | 180718 | 3% | 23% | 5 |
| 4 | ANTIPARKINSON AGENT DETERMINACAO | authKW | 159039 | 1% | 100% | 1 |
| 5 | ANTIPARKINSONIAN DRUGS IN VITRO STUDIES | authKW | 159039 | 1% | 100% | 1 |
| 6 | BI2O3 NANOPOWDER | authKW | 159039 | 1% | 100% | 1 |
| 7 | BIO ANALYTICAL | authKW | 159039 | 1% | 100% | 1 |
| 8 | BLOOD MONONUCLEAR CELLS PMBCS | authKW | 159039 | 1% | 100% | 1 |
| 9 | C172 NEURAL STEM CELL | authKW | 159039 | 1% | 100% | 1 |
| 10 | CAMPUS BENJAMIN FRANKLINSEKT KLIN NEUROBIOL | address | 159039 | 1% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Neurosciences | 1330 | 48% | 0% | 93 |
| 2 | Pharmacology & Pharmacy | 228 | 22% | 0% | 42 |
| 3 | Clinical Neurology | 82 | 10% | 0% | 20 |
| 4 | Biochemical Research Methods | 71 | 7% | 0% | 14 |
| 5 | Biochemistry & Molecular Biology | 71 | 20% | 0% | 38 |
| 6 | Chemistry, Analytical | 67 | 9% | 0% | 18 |
| 7 | Cell Biology | 16 | 7% | 0% | 13 |
| 8 | Materials Science, Biomaterials | 12 | 2% | 0% | 3 |
| 9 | Chemistry, Medicinal | 12 | 3% | 0% | 6 |
| 10 | Biophysics | 9 | 4% | 0% | 7 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | CAMPUS BENJAMIN FRANKLINSEKT KLIN NEUROBIOL | 159039 | 1% | 100% | 1 |
| 2 | CHEMOPHARMACOL SCI | 159039 | 1% | 100% | 1 |
| 3 | CICLE CELLULAR EUCARIOTA | 159039 | 1% | 100% | 1 |
| 4 | EDIFICIO A 3ER PISO | 159039 | 1% | 100% | 1 |
| 5 | NEUROSCI AUSTRALIA MULTIDISCIPLINARY AMYOTR | 159039 | 1% | 100% | 1 |
| 6 | PEDIAT NEUROPHARMACOL S | 159039 | 1% | 100% | 1 |
| 7 | SEZIONE FARMACOL BIOTECHNOL FARMACOL | 159039 | 1% | 100% | 1 |
| 8 | SFR SANTE LYON EST CIQLE | 159039 | 1% | 100% | 1 |
| 9 | UMS3504 INRA UMS1374 | 159039 | 1% | 100% | 1 |
| 10 | UNITE VIROL HUMAINEU758 | 159039 | 1% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | NEUROTOXICITY RESEARCH | 1456 | 2% | 0% | 3 |
| 2 | BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES | 902 | 1% | 0% | 2 |
| 3 | JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS | 877 | 1% | 0% | 2 |
| 4 | NEUROCHEMICAL RESEARCH | 779 | 3% | 0% | 6 |
| 5 | JOURNAL OF NEUROCHEMISTRY | 752 | 5% | 0% | 10 |
| 6 | NEUROSCIENCE LETTERS | 724 | 6% | 0% | 12 |
| 7 | BIOMEDICAL CHROMATOGRAPHY | 718 | 2% | 0% | 4 |
| 8 | NEW YORK HISTORY | 663 | 1% | 0% | 1 |
| 9 | JOURNAL OF NEURAL TRANSMISSION | 618 | 2% | 0% | 4 |
| 10 | BRAIN RESEARCH | 469 | 6% | 0% | 12 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | RAMIREZ, AD , WONG, SKF , MENNITI, FS , (2003) PRAMIPEXOLE INHIBITS MPTP TOXICITY IN MICE BY DOPAMINE D3 RECEPTOR DEPENDENT AND INDEPENDENT MECHANISMS.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 475. ISSUE 1-3. P. 29-35 | 14 | 70% | 40 |
| 2 | PANCHAL, JG , PATEL, RV , MENON, SK , (2011) DEVELOPMENT AND VALIDATION OF GC/MS METHOD FOR DETERMINATION OF PRAMIPEXOLE IN RAT PLASMA.BIOMEDICAL CHROMATOGRAPHY. VOL. 25. ISSUE 4. P. 524 -530 | 12 | 67% | 8 |
| 3 | SEVIM, S , ERK, N , (2015) VALIDATION OF HIGH PERFORMANCE LIQUID CHROMATOGRAPHIC AND SPECTROPHOTOMETRIC METHODS FOR THE DETERMINATION OF THE ANTIPARKINSON AGENT PRAMIPEXOLE DIHYDROCHLORIDE MONOHYDRATE IN PHARMACEUTICAL PRODUCTS.BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES. VOL. 51. ISSUE 4. P. 879 -891 | 8 | 89% | 0 |
| 4 | MEINEL, J , RADAD, K , RAUSCH, WD , REICHMANN, H , GILLE, G , (2015) CABERGOLINE PROTECTS DOPAMINERGIC NEURONS AGAINST ROTENONE-INDUCED CELL DEATH IN PRIMARY MESENCEPHALIC CELL CULTURE.FOLIA NEUROPATHOLOGICA. VOL. 53. ISSUE 1. P. 29 -40 | 14 | 45% | 0 |
| 5 | RAMISETTI, NR , KUNTAMUKKALA, R , ARNIPALLI, MS , (2015) DEVELOPMENT OF A VALIDATED LC METHOD FOR SEPARATION OF PROCESS-RELATED IMPURITIES INCLUDING THE R-ENANTIOMER OF S-PRAMIPEXOLE ON POLYSACCHARIDE CHIRAL STATIONARY PHASES.CHIRALITY. VOL. 27. ISSUE 7. P. 430 -435 | 10 | 63% | 0 |
| 6 | IRAVANI, MM , SADEGHIAN, M , LEUNG, CCM , TEL, BC , ROSE, S , SCHAPIRA, AH , JENNER, P , (2008) CONTINUOUS SUBCUTANEOUS INFUSION OF PRAMIPEXOLE PROTECTS AGAINST LIPOPOLYSACCHARIDE-INDUCED DOPAMINERGIC CELL DEATH WITHOUT AFFECTING THE INFLAMMATORY RESPONSE.EXPERIMENTAL NEUROLOGY. VOL. 212. ISSUE 2. P. 522-531 | 18 | 38% | 18 |
| 7 | PAWAR, SM , DHANESHWAR, SR , (2011) APPLICATION OF STABILITY INDICATING HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHIC METHOD FOR QUANTITATION OF PRAMIPEXOLE IN PHARMACEUTICAL DOSAGE FORM.JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES. VOL. 34. ISSUE 16. P. 1664-1675 | 7 | 88% | 1 |
| 8 | IRAVANI, MM , HADDON, CO , COOPER, JM , JENNER, P , SCHAPIRA, AH , (2006) PRAMIPEXOLE PROTECTS AGAINST MPTP TOXICITY IN NON-HUMAN PRIMATES.JOURNAL OF NEUROCHEMISTRY. VOL. 96. ISSUE 5. P. 1315 -1321 | 12 | 50% | 50 |
| 9 | GU, M , IRVANI, M , COOPER, JM , KING, D , JENNER, P , SCHAPIRA, AHV , (2004) PRAMIPEXOLE PROTECTS AGAINST APOPTOTIC CELL DEATH BY NON-DOPAMINERGIC MECHANISMS.JOURNAL OF NEUROCHEMISTRY. VOL. 91. ISSUE 5. P. 1075 -1081 | 12 | 52% | 58 |
| 10 | BOZAL-PALABIYIK, B , USLU, B , (2016) COMPARATIVE STUDY FOR VOLTAMMETRIC INVESTIGATION AND TRACE DETERMINATION OF PRAMIPEXOLE AT BARE AND CARBON NANOTUBE-MODIFIED GLASSY CARBON ELECTRODES.IONICS. VOL. 22. ISSUE 12. P. 2519 -2528 | 11 | 42% | 0 |
Classes with closest relation at Level 1 |